Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Subjects

Subjects :

Psoriasis -- Drug therapy
Cytokines -- Physiological aspects
Etanercept -- Dosage and administration
Etanercept -- Patient outcomes
Etanercept -- Product development
Clinical trials -- Management
Company business management

Details

Language :

English

ISSN :

01406736

Volume :

367

Issue :

9504

Database :

Gale General OneFile

Journal :

The Lancet

Publication Type :

Academic Journal

Accession number :

edsgcl.140912762